Accuracy Coverage Pricing Contact

Dechra increases its 2018 full year dividend by 18.9%

Investment Tools Ltd.
Dechra increases its 2018 full year dividend by 18.9%

Dechra Pharmaceuticals 2018 final results

Strong financial performance:

Revenue growth of 13.9% to £407.1 million.

Underlying operating profit growth of 24.0% to £99.2 million.

Underlying EBIT margin expansion of 200 bps to 24.4%.

Underlying diluted EPS increased by 20.9% to 76.45 pence.

Full year dividend of 25.50 pence, up 18.9%.

Companies mentioned

Latest News

Investment Tools Limited

Avon Rubber 2018 final results

Read more
Investment Tools Limited

Workspace 2019 interim results

Read more
Investment Tools Limited

Land Securities 2018 interim results

Read more
Investment Tools Limited

DCC 2019 interim results

Read more
Investment Tools Limited

B&M European value retail 2019 interim results

Read more
Investment Tools Limited

Adept technology 2019 interim results

Read more
Investment Tools Limited

Softcat 2018 final results

Read more
Investment Tools Limited

Bellway 2018 final results

Read more
Investment Tools Limited

Ferguson 2018 Final results

Read more
Investment Tools Limited

Inland Homes 2018 final results

Read more
More News